Genetics Research Center, the University of Social Welfare and Rehabilitation Science, Tehran, Iran.
Department of Surgery, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
J Clin Lab Anal. 2023 Mar;37(5):e24846. doi: 10.1002/jcla.24846. Epub 2023 Mar 6.
Angiotensin I converting enzyme 2 (ACE-2) is the most important receptor and has important role in the entry of corona virus to the host cells. The present study aimed to investigate the different mechanisms involved in the expression regulation of this gene among the COVID-19 patients.
A total of 140 patients with COVID-19 (n = 70 mild COVID-19, n = 70 ARDS) and 120 controls were recruited. The expression of ACE-2 and miRNAs was evaluated by quantitative real-time PCR (QRT-PCR), and methylation of CpG dinucleotides in the ACE2 promoter was quantified using bisulfite pyro-sequencing. Finally, different polymorphisms of the ACE-2 gene were studied by Sanger sequencing.
Our results showed a significant high expression of the ACE-2 gene in the blood samples of acute respiratory distress syndrome (ARDS) patients (3.8 ± 0.77) in comparison with controls (0.88 ± 0.12; p < 0.03). The methylation rate of the ACE-2 gene in ARDS patients was 14.07 ± 6.1 compared with controls (72.3 ± 5.1; p < 0.0001). Among the four studied miRNAs, only miR200c-3p showed significant downregulation in ARDS patients (0.14 ± 0.1) in comparison with controls (0.32 ± 0.17; p < 0.001). We did not see a substantial difference in the frequency of rs182366225 C>T and rs2097723 T>C polymorphisms between patients and controls (p > 0.05). There was a significant correlation between B12 (R = 0.32, p < 0.001), folate (R = 0.37, p < 0.001) deficiency, and hypo-methylation of the ACE-2 gene.
These results for the first time indicated that among the different mechanisms of ACE-2 expression regulation, its promoter methylation is very crucial and can be affected by factors involved in one-carbon metabolisms such as B9 and B12 vitamins deficiency.
血管紧张素转换酶 2(ACE-2)是最重要的受体,在冠状病毒进入宿主细胞的过程中起着重要作用。本研究旨在探讨 COVID-19 患者中该基因表达调控的不同机制。
共招募了 140 名 COVID-19 患者(n=70 例轻症 COVID-19,n=70 例 ARDS)和 120 名对照者。采用实时荧光定量 PCR(QRT-PCR)评估 ACE-2 和 miRNA 的表达,采用亚硫酸氢盐焦磷酸测序定量 CpG 二核苷酸的甲基化。最后,通过 Sanger 测序研究 ACE-2 基因的不同多态性。
我们的结果显示,急性呼吸窘迫综合征(ARDS)患者血液样本中 ACE-2 基因的表达显著升高(3.8±0.77),与对照组(0.88±0.12;p<0.03)相比。ARDS 患者 ACE-2 基因的甲基化率为 14.07±6.1,与对照组(72.3±5.1;p<0.0001)相比。在研究的四种 miRNA 中,只有 miR200c-3p 在 ARDS 患者中表达显著下调(0.14±0.1),与对照组(0.32±0.17;p<0.001)相比。患者和对照组之间 rs182366225 C>T 和 rs2097723 T>C 多态性的频率没有显著差异(p>0.05)。B12(R=0.32,p<0.001)和叶酸(R=0.37,p<0.001)缺乏与 ACE-2 基因的低甲基化之间存在显著相关性。
这些结果首次表明,在 ACE-2 表达调控的不同机制中,其启动子甲基化非常重要,并且可以受到涉及一碳代谢的因素的影响,如 B9 和 B12 维生素缺乏。